Accession Number: | 0001125345-20-000115 |
Date: | 2020-07-02 |
Issuer: | MACROGENICS INC (MGNX) |
Original Submission Date: |
RISSER ERIC BLASIUS
9704 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-07-02 | M | 3,100 | a | $1.51 | 47,568 | direct | ||
COMMON STOCK | 2020-07-02 | S | 3,100 | d | $30.00 | 44,468 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 1.51 | 2020-07-02 | deemed execution date | M | 3,100 (d) | 2013-07-06 | 2023-01-05 | common stock 3,100 | $1.51 | 16,000 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on december 5, 2019. |